Don’t love the results, don’t hate them. My decision will have to wait until the details of the strategic review are known in 3 months. Seems like they are taking the right measures to rectify the impacts of clients delaying projects due to covid and IT wage pressures.
- Forums
- ASX - By Stock
- BVS
- Ann: FY22 Results Presentation
BVS
bravura solutions limited.
Add to My Watchlist
0.22%
!
$2.24

Ann: FY22 Results Presentation, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.24 |
Change
-0.005(0.22%) |
Mkt cap ! $1.008B |
Open | High | Low | Value | Volume |
$2.22 | $2.27 | $2.21 | $366.5K | 163.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 4351 | $2.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.24 | 9848 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 4351 | 2.230 |
16 | 18297 | 2.220 |
12 | 19958 | 2.210 |
7 | 53221 | 2.200 |
1 | 2455 | 2.190 |
Price($) | Vol. | No. |
---|---|---|
2.240 | 9838 | 20 |
2.250 | 23842 | 17 |
2.260 | 39024 | 13 |
2.270 | 38549 | 7 |
2.280 | 8761 | 5 |
Last trade - 11.42am 18/06/2025 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online